INDV Projected Dividend Yield
Indivior Pharmaceuticals Inc ( NASDAQ : INDV )Indivior is a holding company. Through its subsidiaries, Co. is engaged in the development, manufacture and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence, and co-occurring disorders. Co.'s products include SUBLOCADE® (buprenorphine extended-release) injection CIII for the treatment of opioid use disorderand PERSERIS® (risperidone) for the treatment of schizophrenia in adults. 10 YEAR PERFORMANCE RESULTS |
|
INDV Dividend History Detail INDV Dividend News INDV Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2026 |
Sep 16, 2026 |
Nov 03, 2026 |
Oct 30, 2026 |
Nov 06, 2026 |
8.1300 |
2026 Total: |
8.1300 |


